GDS Ramsay Generale de Sante

RAMSAY SANTE : Availability of the Universal Registration Document 2023

RAMSAY SANTE : Availability of the Universal Registration Document 2023

RELEASE

                Paris, le 27 October 2023

AVAILABILITY OF THE UNIVERSAL REGISTRATION DOCUMENT 2023

Paris, 27 October 2023

Ramsay Générale de Santé's 2023 Universal Registration Document was filed with the Autorité des marchés financiers (AMF) in ESEF (European Single Electronic Format) on Friday 27 October 2023, under number D.23-0778. It is available to the public under the conditions provided for by the regulations in force and can be consulted on the Ramsay Santé website:

The Universal Registration Document is also available on the AMF website -france.org)

The Universal Registration Document, prepared for the year ended 30 June 2023, includes, inter alia

  • the annual financial report and the integrated report,
  • the Board of Directors' report on corporate governance,
  • the management report, including the extra-financial performance declaration
  • the auditors' reports and information on their fees,
  • the description of the share buyback programme.



It also includes information relating to the social, environmental and societal responsibility of the Ramsay Health Group.

About Ramsay Santé

Ramsay Santé is the leader in private hospitalisation and primary care in Europe. The Group has 38,000 employees and works with nearly 9,300 practitioners to treat more than 10 million patients per year in its 443 facilities and 5 countries: France, Sweden, Norway, Denmark and Italy.

Ramsay Santé offers almost all medical and surgical specialities in three domains: Medicine, Surgery, Obstetrics (MSO), Follow-up Care and Rehabilitation (FCR) and Mental Health. In all its territories, the Group contributes to public service health undertakings and providing proximity care, as in Sweden where the group has more than a hundred local health centres. Safe, quality care is the Group's priority in all the countries where it operates. This is what has made it a reference in state-of-the-art medicine, particularly in outpatient surgery and enhanced recovery after surgery (ERAS). The Group also invests more than €200 million every year in its facilities, whether in new surgical and imaging technologies or in the construction and modernisation of facilities. To best serve patient interests, it innovates constantly with new digital tools and by developing its organisations to improve efficiency of care.

Facebook :

Instagram :

Twitter :

LinkedIn :

YouTube :

ISIN code and Euronext Paris: FR0000044471

Website: fr

Investor Relations/Analysts        Press Relations

Jerome Brice        Brigitte Cachon

Tel. 88        Tél. 11  

        

Attachment



EN
27/10/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ramsay Generale de Sante

 PRESS RELEASE

Ramsay Sante : Provisional annual Results at the end of June 2025

Ramsay Sante : Provisional annual Results at the end of June 2025         PRESS RELEASE                 Paris, 27th August 2025 Provisional annual results at the end of June 2025Revenue growth of 4.7% and Group EBITDA up 1.7% despite reduction in public funding; secured long term financing framework Activity growth and cost control mitigate low French tariffs Group revenue increased by 4.7% to €5.2bn supported by activity volume growth and former Cosem primary care centres acquired in June 2024. Revenue growth of 2.7% on a like-for-like basis.Group EBITDA reported for the year ended Jun...

 PRESS RELEASE

RAMSAY SANTE : résultats annuels provisoires à fin juin 2025

RAMSAY SANTE : résultats annuels provisoires à fin juin 2025         COMMUNIQUÉ DE PRESSE                Paris, le 27 août 2025 Résultats annuels provisoires à fin juin 2025Croissance du chiffre d'affaires de 4,7 % et EBITDA en hausse de 1,7 % malgré une baisse du financement public ; structure de financement long terme assurée Croissance d’activité et contrôle des coûts viennent atténuer des tarifs insuffisants en France Le chiffre d'affaires du groupe a augmenté de 4,7% à 5,2 milliards d'euros, soutenu par la hausse du volume d'activité et l'acquisition en juin 2024 des centres de soin...

 PRESS RELEASE

Ramsay Generale de Sante : Natalie Davis appointment as Chairwoman of ...

Ramsay Generale de Sante : Natalie Davis appointment as Chairwoman of the Board PRESS RELEASEParis, 26th June 2025 Ramsay Générale de Santé Board of Directors appoints Natalie Davis as Chairman of the Board At its meeting today, the Board of Directors announced the appointment of Natalie Davis as Chairman of the Board of Directors. She succeeds Craig McNally, who is stepping down from this position, which he has held since 2017. "On behalf of the entire Ramsay Santé Group team, I would like to offer Craig McNally our sincerest thanks for his eight years of exemplary commitment as Chair...

 PRESS RELEASE

RAMSAY GENERALE DE SANTE : nomination de Natalie Davis Présidente du C...

RAMSAY GENERALE DE SANTE : nomination de Natalie Davis Présidente du Conseil d'Administration 26 juin 2025 COMMUNIQUÉ DE PRESSEParis, le 26 juin 2025 Le Conseil d’Administration de Ramsay Générale de Santé nomme Natalie Davis Présidente du Conseil Le Conseil d’administration réuni ce jour, annonce la nomination de Natalie Davis au poste de Présidente du Conseil d’Administration. Elle succède à Craig McNally qui quitte cette fonction qu’il occupait depuis 2017. «Au nom de l’ensemble des équipes du groupe Ramsay Santé, je tiens à adresser, à Craig McNally nos remerciements les plus sincè...

 PRESS RELEASE

RAMSAY SANTE : Interim results at the end of March 2025

RAMSAY SANTE : Interim results at the end of March 2025         PRESS RELEASE                Paris, 14th May 2025 Interim results at the end of March 2025 Activity growth and cost control compensate pricing headwinds Unaudited group revenue for the nine months period ending 31 March 2025 increased by 5.1% to 3.9bn€ supported by activity volume growth and Cosem primary care centres acquired in June 2024. Revenue growth of 3.2% on a like-for-like basis.Unaudited group EBITDA for the nine months period ending 31 March 2025 was almost stable at 441m€, -0.8% or -3.6m€ compared to the prior ye...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch